ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

VER Vernalis

6.17
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Vernalis LSE:VER London Ordinary Share GB00B3Y5L754 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 6.17 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Vernalis Share Discussion Threads

Showing 1576 to 1598 of 3850 messages
Chat Pages: Latest  70  69  68  67  66  65  64  63  62  61  60  59  Older
DateSubjectAuthorDiscuss
15/5/2007
14:12
That's a lot of sells and the price didn't budge!
fhmktg
15/5/2007
08:56
Fellner has a reputation as a deal maker. Frova approval for PM migraine could trigger some action?
fhmktg
12/5/2007
12:59
Thanks for info maiseymouse and Elgordo. This company has income streams which should grow with expected US drug approval in near future. Nice to see a bio company with established products in the market and a good flow of drugs in research stage.
penbroker
12/5/2007
10:29
Tipped as "gamble of the week" by Paul Hill in this week's MoneyWeek.

Concludes with reminder of PiperJaffray and Goldmans Sachs price targets of 123p and 86p, and that Vernalis "could become a takeover target".

elgordo
08/5/2007
12:12
A bit of support from bridgewell Granted it is looking towards the Parkinson's drugs, but I think we may see a tick up ahead of the Frova announcement.
maiseymouse
08/5/2007
10:09
am not in the UK...forgot you guys had a holiday..... : )
thecynical1
07/5/2007
10:24
We are closed today!
fhmktg
07/5/2007
08:32
morning all....if there is anyone out there that is.....has anyone any idea why the offer is so far out ? or is my monitor playing games? I am seeing 83p on the offer.....are the MMs expecting something ?
thecynical1
24/4/2007
14:05
SPT (Spirent Communications plc) is also thought to be considering de-listing from the American exchanges due to the expense in time and money for very extra benefit.

The Sarbanes-Oxley Act, although well intentioned in terms of making financial matters visible, in my experience appears to have had the opposite effect. This might well be due to other factors which I have not really considered.

mmamuk2
24/4/2007
11:22
I personally think a delisting from the Nasdaq is a good thing and I have always been against it for Small Biotechs.

It is a huge amount of expense in time and money for very little gain. It would be interesting to see exactly how much has been traded in total since listing.

Back to business imo.

vow
23/4/2007
16:57
Indeed. Excellent news. Fingers crossed for Frova!
iancath
23/4/2007
14:20
Thanks el gordo!
fhmktg
23/4/2007
11:19
The rise continues. Does anyone have any idea if there's something behind it?
I've searched around and come up with nothing yet.

iancath
20/4/2007
12:04
Anything in the Investors Chronicle today?

Could be early optimism about Frova for menstrual migraine - though not now due before August.

fhmktg
20/4/2007
11:53
why the rise ??are there any reports due for publication.
barrie16
20/4/2007
11:50
chatterbox

That is right have started on the UP this morning and volume has push the share to 5p up now

Most likely was due to a late trade 16.40pm for 56K share at middle price

master rsi
20/4/2007
11:44
nice little rise today
chatterbox
11/4/2007
15:02
Up 11% in early trading on NASDQ - some promotional activity over the pond?
fhmktg
10/4/2007
23:27
YES the climb continues though in a small pace
master rsi
03/4/2007
22:35
thanks master rsi, I believe this will climb slowly and am in for the long term but currently 40% down.
4screws
03/4/2007
13:38
Slowly going higher again today

10 days chart

master rsi
02/4/2007
15:06
Other Parkinson's Drugs Not Affected

Permax belongs to a class of drugs called dopamine agonists. Today's action doesn't affect any other dopamine agonists or other types of Parkinson's disease drugs.

It clearly states that other dopamine agonists are unaffected by the withdrawal and the market has reacted positively to the news.

iancath
02/4/2007
13:07
I am not sure how this drug sits vis-a-vis Apokyn.. any takers? Maybe a chance for more sales...
rfinance
Chat Pages: Latest  70  69  68  67  66  65  64  63  62  61  60  59  Older

Your Recent History

Delayed Upgrade Clock